PE55396A1 - Formulacion de cafeina con retardo sostenido - Google Patents
Formulacion de cafeina con retardo sostenidoInfo
- Publication number
- PE55396A1 PE55396A1 PE1995286458A PE28645895A PE55396A1 PE 55396 A1 PE55396 A1 PE 55396A1 PE 1995286458 A PE1995286458 A PE 1995286458A PE 28645895 A PE28645895 A PE 28645895A PE 55396 A1 PE55396 A1 PE 55396A1
- Authority
- PE
- Peru
- Prior art keywords
- caffeine
- layer
- formulation
- internal layer
- stimulant
- Prior art date
Links
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001948 caffeine Drugs 0.000 title abstract 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- 230000002459 sustained effect Effects 0.000 title 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 229920002472 Starch Polymers 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
- 239000011368 organic material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 230000001012 protector Effects 0.000 abstract 1
- 239000002195 soluble material Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 229920001059 synthetic polymer Polymers 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 229940075420 xanthine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
SE REFIERE A LA COMPOSICION PARA LA LIBERACION CONTROLADA DE UN ESTIMULANTE DE XANTINA O DERIVADO DE XANTINA, LA CUAL COMPRENDE MICROPARTICULAS QUE INCLUYEN UN NUCLEO (1) DE UN MATERIAL ORGANICO TAL COMO UN POLISACARIDO, AZUCAR O UN DERIVADO DE AZUCAR Y OPCIONALMENTE UN DILUYENTE COMO ALMIDON; CAPAS INTERIOR Y EXTERIOR (2) DE LA MATRIZ Y UN RECUBRIMIENTO INTERMEDIO (5); LA CAPA INTERNA (2) ILUSTRA LA PARTICULA DE CAFEINA (3) Y EL LIGANTE DE UN MATERIAL HIDROSOLUBLE (4) TAL COMO UN POLIMERO SINTETICO, ESTA CAPA INCLUYE ENTRE 55% Y 95% DE LA CANTIDAD DE CAFEINA DESTINADA A LA FORMULACION; LA CAPA (5) REPRESENTA EL RECUBRIMIENTO TAL COMO GOMA LACA Y TALCO QUE FUNCIONA COMO UN PROTECTOR PARA REDUCIR LA LIBERACION DE CAFEINA DESDE LA CAPA INTERNA (2); LA CAPA EXTERNA (6) ES DE COMPOSICION SIMILAR A LA (2), CON LA EXCEPCION QUE ES APLICADA A UN MENOR ESPESOR QUE LA CAPA INTERNA Y CONTIENE DE 5% A 45% DEL TOTAL DEL ESTIMULANTE EN LA FORMULACION. ES USADO PARA AUMENTAR EL ESTADO DE ALERTA DE UN INDIVIDUO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/357,689 US5744164A (en) | 1994-12-16 | 1994-12-16 | Sustained release microparticulate caffeine formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE55396A1 true PE55396A1 (es) | 1996-12-24 |
Family
ID=23406640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995286458A PE55396A1 (es) | 1994-12-16 | 1995-12-05 | Formulacion de cafeina con retardo sostenido |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5744164A (es) |
| EP (2) | EP0716853A1 (es) |
| JP (1) | JPH10510529A (es) |
| AR (1) | AR002947A1 (es) |
| AT (1) | ATE201986T1 (es) |
| AU (1) | AU694810B2 (es) |
| CA (1) | CA2208149C (es) |
| CO (1) | CO4600671A1 (es) |
| DE (1) | DE69521328T2 (es) |
| DK (1) | DK0789562T3 (es) |
| ES (1) | ES2158956T3 (es) |
| GR (1) | GR3036501T3 (es) |
| HK (1) | HK1000878A1 (es) |
| IL (1) | IL116066A (es) |
| NZ (1) | NZ295245A (es) |
| PE (1) | PE55396A1 (es) |
| PT (1) | PT789562E (es) |
| RU (1) | RU2144353C1 (es) |
| TR (1) | TR199501560A2 (es) |
| WO (1) | WO1996018389A1 (es) |
| ZA (1) | ZA9510687B (es) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6122496A (en) * | 1995-06-20 | 1997-01-22 | Pharma-Vinci A/S | A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
| US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
| US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
| US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
| US7163705B2 (en) * | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
| US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
| US20020159956A1 (en) * | 1999-04-06 | 2002-10-31 | Ream Ronald L. | Over-coated chewing gum formulations |
| US7935362B2 (en) * | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
| US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
| US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
| US6426090B1 (en) * | 1999-04-06 | 2002-07-30 | Wm. Wrigley Jr. Company | Over-coated product including tableted center and medicament |
| US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
| US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
| US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
| US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
| US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
| US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
| WO2001021147A1 (en) * | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
| US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
| US7115297B2 (en) | 2000-02-22 | 2006-10-03 | Suzanne Jaffe Stillman | Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
| US8178150B2 (en) | 2000-02-22 | 2012-05-15 | Suzanne Jaffe Stillman | Water containing soluble fiber |
| US7892586B2 (en) | 2001-02-22 | 2011-02-22 | Suzanne Jaffe Stillman | Water containing soluble fiber |
| US7115288B2 (en) * | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
| US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
| RU2166945C1 (ru) * | 2000-08-08 | 2001-05-20 | Ефимова Лариса Степановна | Радиосенсибилизирующее вещество для лечения онкологических заболеваний |
| US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
| US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
| US7897141B2 (en) * | 2002-04-01 | 2011-03-01 | Drexel University | Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof |
| US20030220351A1 (en) * | 2002-05-24 | 2003-11-27 | Gilbert Gonzales | Enteric coated caffeine tablet |
| EP1565062A1 (en) * | 2002-11-25 | 2005-08-24 | Phares Pharmaceutical Research N.V. | Confectionery composition |
| US20050181044A1 (en) * | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements, green coffee extract |
| US20050220875A1 (en) * | 2004-03-31 | 2005-10-06 | Agency For Science, Technology And Research | Sustained-release tablet formulation |
| FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
| US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| US8110226B2 (en) * | 2007-07-20 | 2012-02-07 | Mylan Pharmaceuticals Inc. | Drug formulations having inert sealed cores |
| US8044021B2 (en) * | 2007-09-20 | 2011-10-25 | Abbott Cardiovascular Systems Inc. | Sustained release of apo A-I mimetic peptides and methods of treatment |
| US8101565B2 (en) * | 2007-09-20 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
| US7985728B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
| US9173890B2 (en) * | 2007-09-20 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
| US7985727B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Apo A-I mimetic peptides and methods of treatment |
| AU2010211985A1 (en) * | 2009-01-22 | 2011-08-11 | Abbott Healthcare Private Limited | Chronotherapeutic pharmaceutical composition |
| US8545892B2 (en) | 2009-06-26 | 2013-10-01 | Nano Pharmaceutical Laboratories, Llc | Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| US8992898B2 (en) | 2010-04-17 | 2015-03-31 | Shannon Elizabeth Klingman | Antiperspirants and deodorants |
| US20160128943A1 (en) * | 2013-06-04 | 2016-05-12 | KVK-Tech, Inc. | Controlled release caffeine dosage forms |
| CA2978593A1 (en) | 2015-01-12 | 2016-07-21 | Nano Pharmaceutical Laboratories Llc | Layered sustained-release microbeads and methods of making the same |
| KR101644154B1 (ko) * | 2015-09-08 | 2016-07-29 | 주식회사 스킨앤테크 | 수용성 카페인 및 그 제조방법 |
| US10582716B1 (en) | 2019-06-14 | 2020-03-10 | Lennham Pharmaceuticals, Inc. | Deuterated caffeine and uses thereof |
| US12194046B2 (en) * | 2021-03-09 | 2025-01-14 | Lennham Pharmaceuticals, Inc. | D9-caffeine compositions and uses thereof |
| JP2024525962A (ja) * | 2021-07-30 | 2024-07-12 | 寶齡富錦生技股▲ふん▼有限公司 | 放出制御型経口製剤及びその調製方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
| DE1249219B (de) * | 1958-12-22 | 1967-09-07 | The National Cash Register Company, Dayton, Ohio (V. St. A.) | Herstellen von Mikrokapseln, die eine Emulsion aus Öl in hydrophiler Flüssigkeit enthalten |
| DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
| US4001480A (en) * | 1974-08-16 | 1977-01-04 | Swift & Company | Encapsulation process utilizing microorganisms and products produced thereby |
| IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
| NZ207813A (en) * | 1983-06-24 | 1986-12-05 | Dridrinks Nv | Effervescent mixture:component(s)coated with water-soluble polysaccharide composition |
| EP0185127B1 (fr) * | 1983-06-24 | 1988-09-21 | Dridrinks N.V. | Procédé de traitement d'acides utilisés comme constituants d'une composition pulvérulente hydrosoluble pour boissons à dégagement gazeux prolongé |
| NZ210785A (en) * | 1984-01-13 | 1987-11-27 | Battelle Development Corp | Liquid dispersions of layered controlled release dosage forms |
| DE3403329A1 (de) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
| DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| AU571312B2 (en) * | 1984-02-10 | 1988-04-14 | Nycomed Danmark A/S | Diffusion coated multiple-units dosage form |
| NL8500724A (nl) * | 1985-03-13 | 1986-10-01 | Univ Groningen | Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. |
| DE3537770A1 (de) * | 1985-10-24 | 1987-04-30 | Basf Ag | Salze mehrwertiger kationen von polymerisaten von konjugierten dienen |
| US4853249A (en) * | 1985-11-15 | 1989-08-01 | Taisho Pharmaceutical Co., Ltd. | Method of preparing sustained-release pharmaceutical/preparation |
| JP2541835B2 (ja) * | 1986-04-07 | 1996-10-09 | ローヌ―プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド | 持続放出型薬理組成物の製法およびこれにより得られる組成物 |
| US5026709A (en) * | 1986-04-07 | 1991-06-25 | Rorer Pharmaceutical Corporation | Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby |
| GB8613689D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| US5200193A (en) * | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
| JP2643222B2 (ja) * | 1988-02-03 | 1997-08-20 | エーザイ株式会社 | 多重層顆粒 |
| US4971785A (en) * | 1988-03-14 | 1990-11-20 | Spectrum Consumer Products Co., Inc. | Non-alcoholic delivery system for orally ingestible active ingredients |
| US5330766A (en) * | 1989-01-06 | 1994-07-19 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
| CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
| US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
| JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
-
1994
- 1994-12-16 US US08/357,689 patent/US5744164A/en not_active Expired - Lifetime
-
1995
- 1995-03-17 EP EP95103931A patent/EP0716853A1/en not_active Withdrawn
- 1995-11-20 IL IL11606695A patent/IL116066A/xx not_active IP Right Cessation
- 1995-11-27 ES ES95936707T patent/ES2158956T3/es not_active Expired - Lifetime
- 1995-11-27 CA CA002208149A patent/CA2208149C/en not_active Expired - Lifetime
- 1995-11-27 AU AU38542/95A patent/AU694810B2/en not_active Expired
- 1995-11-27 RU RU97111886A patent/RU2144353C1/ru active
- 1995-11-27 AT AT95936707T patent/ATE201986T1/de active
- 1995-11-27 WO PCT/IB1995/001056 patent/WO1996018389A1/en not_active Ceased
- 1995-11-27 PT PT95936707T patent/PT789562E/pt unknown
- 1995-11-27 DE DE69521328T patent/DE69521328T2/de not_active Expired - Lifetime
- 1995-11-27 HK HK97102557A patent/HK1000878A1/en not_active IP Right Cessation
- 1995-11-27 DK DK95936707T patent/DK0789562T3/da active
- 1995-11-27 EP EP95936707A patent/EP0789562B1/en not_active Expired - Lifetime
- 1995-11-27 NZ NZ295245A patent/NZ295245A/xx not_active IP Right Cessation
- 1995-11-27 JP JP8518527A patent/JPH10510529A/ja active Pending
- 1995-12-05 PE PE1995286458A patent/PE55396A1/es not_active Application Discontinuation
- 1995-12-11 AR ARP950100500A patent/AR002947A1/es unknown
- 1995-12-12 TR TR95/01560A patent/TR199501560A2/xx unknown
- 1995-12-14 CO CO95059167A patent/CO4600671A1/es unknown
- 1995-12-15 ZA ZA9510687A patent/ZA9510687B/xx unknown
-
1996
- 1996-08-16 US US08/698,621 patent/US5700484A/en not_active Expired - Lifetime
-
2001
- 2001-08-31 GR GR20010401361T patent/GR3036501T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE201986T1 (de) | 2001-06-15 |
| EP0789562A1 (en) | 1997-08-20 |
| TR199501560A2 (tr) | 1996-07-21 |
| IL116066A (en) | 2000-10-31 |
| CO4600671A1 (es) | 1998-05-08 |
| CA2208149C (en) | 2007-03-27 |
| HK1000878A1 (en) | 2001-10-26 |
| US5700484A (en) | 1997-12-23 |
| PT789562E (pt) | 2001-10-30 |
| AU694810B2 (en) | 1998-07-30 |
| NZ295245A (en) | 1999-01-28 |
| EP0789562B1 (en) | 2001-06-13 |
| DE69521328D1 (de) | 2001-07-19 |
| EP0716853A1 (en) | 1996-06-19 |
| RU2144353C1 (ru) | 2000-01-20 |
| JPH10510529A (ja) | 1998-10-13 |
| CA2208149A1 (en) | 1996-06-20 |
| AR002947A1 (es) | 1998-05-27 |
| IL116066A0 (en) | 1996-01-31 |
| ZA9510687B (en) | 1996-07-03 |
| AU3854295A (en) | 1996-07-03 |
| DE69521328T2 (de) | 2002-01-17 |
| US5744164A (en) | 1998-04-28 |
| WO1996018389A1 (en) | 1996-06-20 |
| DK0789562T3 (da) | 2001-09-03 |
| GR3036501T3 (en) | 2001-11-30 |
| ES2158956T3 (es) | 2001-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE55396A1 (es) | Formulacion de cafeina con retardo sostenido | |
| AR011059A1 (es) | Composicion para revestimiento de pelicula seca para formar una suspension de revestimiento para revestir suplementos nutricionales, tabletas farmaceuticas y similares, y metodo para revestir sustratos tales como suplementos nutricionales, tabletas farmaceuticas, y similares, con un revestimiento de | |
| ES8801937A1 (es) | Metodo para la obtencion de un material de estanqueidad apropiado para proteger un substrato. | |
| BR0014883A (pt) | Implante revestido biocompatìvel | |
| ES2053845T3 (es) | Agente para despegue de barnices y sedimentacion. | |
| ES2184997T3 (es) | Particula de aditivo para la colada con revestimientos de superficies multiples. | |
| DK1077727T3 (da) | Sammensætning til adhæsiv mikrosfærelægemiddelafgivelse | |
| AR015129A1 (es) | Composiciones de recubrimiento de carbamato curables y metodo para mejorar la adherencia. | |
| IT942571B (it) | Fodera interna per calzature con rivestimento adesivo fusible e relativo procedimento di incollag gio | |
| GB1258705A (es) | ||
| ES554465A0 (es) | Un procedimiento para la preparacion de una composicion de recubrimiento util como capa de imprimacion para carrocerias de automoviles y camiones. | |
| AU6148000A (en) | Ceramic material, method for the production thereof, use of the ceramic material, and a layer of the ceramic material on a metallic or ceramic body | |
| CL2003002356A1 (es) | Compuestos derivados de 1-(1-acetil-piperidin-4-il)-(ester o amida)-4-(bencidrilo sustituido)-2-tert-butil-piperazina, composicion farmaceutica, y su uso en la inhibicion de 17b-hidroxiesteroide deshidrogenasa de tipo 3 y de enfermedades que dependen | |
| EP0379933A3 (de) | Superfizielles therapeutisches System mit einem Gehalt an einem antineoplastischen Wirkstoff, insbesondere 5-Fluoruracil | |
| ES2096955T3 (es) | Procedimiento para fabricar placas compuestas. | |
| GB1511915A (en) | Methods of repairing lacquer damage and clear lacquer compositions for carrying the methods into effect | |
| US2310292A (en) | Gummed body | |
| ES2167822T3 (es) | Procedimiento para la obtencion de granulados de hidroxipivalato de neopentilglicol exentos de aglutinado. | |
| US3018106A (en) | Bowling pin | |
| CN205577764U (zh) | 一种应用于卧室内的隔音保温木门 | |
| DE529845C (de) | Leimband-Fliegenfaenger | |
| US2271413A (en) | Decalcomania and the like | |
| NL187198C (nl) | Werkwijze voor het vervaardigen van vlakdrukplaatdragers van aluminium door elektrochemisch ruwen van het oppervlak. | |
| JP2003335584A (ja) | 耐熱性基体の接合方法、装飾品、及びその製造方法 | |
| EP2559676B1 (de) | Kleber- oder putzmasse umfassend ein minerales bindemittel und ein schichtsilikat sowie beschichtungssystem und dämmsystem umfassend eine beschichtungsmasse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |